PuSH - Publication Server of Helmholtz Zentrum München

A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes.

EBioMedicine 82:104118 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: Diabetes in childhood and adolescence includes autoimmune and non-autoimmune forms with heterogeneity in clinical and biochemical presentations. An unresolved question is whether there are subtypes, endotypes, or theratypes within these forms of diabetes. METHODS: The multivariable classification and regression tree (CART) analysis method was used to identify subgroups of diabetes with differing residual C-peptide levels in patients with newly diagnosed diabetes before 20 years of age (n=1192). The robustness of the model was assessed in a confirmation and prognosis cohort (n=2722). FINDINGS: The analysis selected age, haemoglobin A1c (HbA1c), and body mass index (BMI) as split parameters that classified patients into seven islet autoantibody-positive and three autoantibody-negative groups. There were substantial differences in genetics, inflammatory markers, diabetes family history, lipids, 25-OH-Vitamin D3, insulin treatment, insulin sensitivity and insulin autoimmunity among the groups, and the method stratified patients with potentially different pathogeneses and prognoses. Interferon-ɣ and/or tumour necrosis factor inflammatory signatures were enriched in the youngest islet autoantibody-positive groups and in patients with the lowest C-peptide values, while higher BMI and type 2 diabetes characteristics were found in older patients. The prognostic relevance was demonstrated by persistent differences in HbA1c at 7 years median follow-up. INTERPRETATION: This multivariable analysis revealed subgroups of young patients with diabetes that have potential pathogenetic and therapeutic relevance. FUNDING: The work was supported by funds from the German Federal Ministry of Education and Research (01KX1818; FKZ 01GI0805; DZD e.V.), the Innovative Medicine Initiative 2 Joint Undertaking INNODIA (grant agreement No. 115797), the German Robert Koch Institute, and the German Diabetes Association.
Impact Factor
Scopus SNIP
Altmetric
11.205
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords C-peptide ; Cart Analysis ; Childhood Autoimmune Disease ; Diabetes Endotypes ; Diabetes In Childhood ; Inflammation ; Islet Autoantibody ; Obesity ; Type 1 Diabetes Genetic Susceptibility
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 2352-3964
e-ISSN 2352-3964
Journal EBioMedicine
Quellenangaben Volume: 82, Issue: , Pages: , Article Number: 104118 Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Reviewing status Peer reviewed
POF-Topic(s) 30201 - Metabolic Health
90000 - German Center for Diabetes Research
30203 - Molecular Targets and Therapies
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502100-001
G-501900-229
G-501900-211
A-630700-001
G-501900-217
G-502600-006
Grants Bundesministerium für Bildung und Forschung
Juvenile Diabetes Research Foundation United States of America
Leona M. and Harry B. Helmsley Charitable Trust
Union's Horizon 2020
Innovative Medicine Initiative 2 Joint Undertaking
German Robert Koch Institute
German Diabetes Association
Fabian Theis
Competence Network Diabetes Mellitus
Scopus ID 85134594390
PubMed ID 35803018
Erfassungsdatum 2022-10-27